This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jie An - Innovator in AKT Inhibition
Introduction
Jie An is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of AKT inhibitors. His work focuses on compounds that can effectively target and inhibit the AKT protein kinase, which plays a crucial role in various diseases.
Latest Patents
Jie An holds 1 patent related to an AKT inhibitor. This invention specifically pertains to a compound represented by a unique formula or a pharmaceutically acceptable salt thereof. The patent also outlines a preparation method for the compound and its application in the prevention and treatment of diseases mediated by AKT protein kinase.
Career Highlights
Throughout his career, Jie An has worked with Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His experience in this organization has allowed him to contribute to innovative research and development projects.
Collaborations
Some of Jie An's notable coworkers include Changyou Ma and Zhoushan Tian. Their collaboration has likely fostered a productive environment for innovation and advancement in their respective fields.
Conclusion
Jie An's work in developing AKT inhibitors showcases his commitment to advancing medical science. His contributions are significant in the ongoing fight against diseases influenced by AKT protein kinase.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile